Atlas Trials

Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Psoriasis

Clinical trial NCT00658827 · COMPLETED

Trial details

NCT number
NCT00658827
Sponsor
Janssen Biotech, Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
Inflammatory Bowel Disease
Start date
2007-01-01
Primary completion
2016-09-30
Enrollment
370

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.